Literature DB >> 22102064

CD99 is expressed in chordoid glioma and suggests ependymal origin.

Alfredo E Romero-Rojas1, Julio A Díaz-Pérez, Lina M Ariza-Serrano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22102064     DOI： 10.1007/s00428-011-1170-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN： 0945-6317            Impact factor:   4.064


× No keyword cloud information.
  15 in total

1.  Origin of chordoid glioma of the third ventricle.

Authors:  Norman E Leeds; Frederick F Lang; Teresa Ribalta; Raymond Sawaya; Gregory N Fuller
Journal:  Arch Pathol Lab Med       Date:  2006-04       Impact factor: 5.534

2.  The elusive origin of chordoid glioma.

Authors:  Daniel J Brat
Journal:  Arch Pathol Lab Med       Date:  2006-04       Impact factor: 5.534

3.  CD99 immunoreactivity in ependymoma.

Authors:  Y L Choi; J G Chi; Y L Suh
Journal:  Appl Immunohistochem Mol Morphol       Date:  2001-06

4.  Chordoid glioma of the third ventricle: an ultrastructural study of three cases with a histogenetic hypothesis.

Authors:  G Cenacchi; F Roncaroli; S Cerasoli; G Ficarra; G A Merli; F Giangaspero
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

5.  Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells.

Authors:  J Held-Feindt; F Forstreuter; T Pufe; R Mentlein
Journal:  Brain Res Mol Brain Res       Date:  2001-02-19

Review 6.  Chordoid glioma: clinicopathologic profile and differential diagnosis of an uncommon tumor.

Authors:  Anna Maria Buccoliero; Adele Caldarella; Pasquale Gallina; Nicola Di Lorenzo; Antonio Taddei; Gian Luigi Taddei
Journal:  Arch Pathol Lab Med       Date:  2004-11       Impact factor: 5.534

7.  Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity.

Authors:  G Reifenberger; T Weber; R G Weber; M Wolter; A Brandis; K Kuchelmeister; P Pilz; E Reusche; P Lichter; O D Wiestler
Journal:  Brain Pathol       Date:  1999-10       Impact factor: 6.508

8.  Suprasellar meningioma with expression of glial fibrillary acidic protein: a peculiar variant.

Authors:  J Wanschitz; M Schmidbauer; H Maier; K Rössler; P Vorkapic; H Budka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  An incidentally detected third ventricle chordoid glioma.

Authors:  Pasquale Gallina; Gastone Pansini; Homére Mouchaty; Regina Mura; Anna Maria Buccoliero; Nicola Di Lorenzo
Journal:  Neurol India       Date:  2007 Oct-Dec       Impact factor: 2.117

10.  Chordoid glioma: report of two rare examples with unusual features.

Authors:  D Jain; M C Sharma; C Sarkar; V Suri; A Rishi; A Garg; S Vaishya
Journal:  Acta Neurochir (Wien)       Date:  2008-02-04       Impact factor: 2.216
View more
  4 in total

Review 1.  Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Authors:  Leonel Ampie; Winward Choy; Jonathan B Lamano; Kartik Kesavabhotla; Qinwen Mao; Andrew T Parsa; Orin Bloch
Journal:  Clin Neurol Neurosurg       Date:  2015-08-19       Impact factor: 1.876

2.  Chordoid glioma: a rare radiologically, histologically, and clinically mystifying lesion.

Authors:  Daniele Bongetta; Andrea Risso; Patrizia Morbini; Giorgio Butti; Paolo Gaetani
Journal:  World J Surg Oncol       Date:  2015-05-28       Impact factor: 2.754

3.  Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment.

Authors:  Christopher Dardis; Jared Yeo; Kelly Milton; Lynn S Ashby; Kris A Smith; Shwetal Mehta; Emad Youssef; Jenny Eschbacher; Kathy Tucker; Laughlin Dawes; Neil Lambie; Elizabeth Algar; Elizabeth Hovey
Journal:  Front Neurol       Date:  2017-06-20       Impact factor: 4.003

4.  Chordoid glioma in the thalamus of a child: Rare location and atypical imaging findings.

Authors:  Cong Huang; Dengwei Gan; Botao Huang; Junde Luo; Xingshun Zhou; Wensheng Wang; Yujun Wang
Journal:  BJR Case Rep       Date:  2021-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.